February 9, 2012
On February 16, 2012, Bracco Diagnostics, Inc will meet with the Nuclear Regulatory Commission (NRC) and the Agreement Staff to discuss the CardioGen-82 re-introduction, labeling and training, user certification and quality control database plans. The meeting will be held from 1:00 p.m. to 4:00 p.m. at the NRC White Flint building in Rockville, MD.
For the full public meeting memo, please see the attached document.